Changzhou Qianhong Biopharma Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Changzhou Qianhong Biopharma Co., Ltd. with three other
companies in this sector in China:
Shenzhen Neptunus Interlong Bio-technique Co Ltd
sales of 759.11 million Chinese Renmimbi [US$110.25 million]
of which 57%
was Manufacturing & selling medicine product),
Jiangxi Fuxiang Pharmaceutical Co Ltd
(763.68 million Chinese Renmimbi [US$110.92 million]
of which 100%
was Pharmaceutical manufacturing industry), and
Shanxi C&Y Pharmaceutical Group Co Ltd
(745.95 million Chinese Renmimbi [US$108.34 million]
of which 74%
was Pharmaceutical Manufacturing).
During the year ended December of 2016, sales at
Changzhou Qianhong Biopharma Co., Ltd. were 776.38 million Chinese Renmimbi (US$112.76 million).
increase of 2.6%
versus 2015, when the company's sales were 757.02 million Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2014, when Changzhou Qianhong Biopharma Co., Ltd.
reported sales of 814.58 million Chinese Renmimbi.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Changzhou Qianhong Biopharma Co., Ltd. had sales
of 737.65 million Chinese Renmimbi.
Sales of Bio-Pharmaceutical Industry saw an increase
2.6% in 2016, from
756.44 million Chinese Renmimbi to 775.85 million Chinese Renmimbi.
Not all segments of Changzhou Qianhong Biopharma Co., Ltd. experienced an increase in sales in 2016:
sales of Other Operations fell 11.9% to 538,105.87 Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).